Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRX319 in Primary or Secondary Progressive Multiple Sclerosis
NCT07477639Phase 2Recruiting
- Sponsor
- Tr1X
- Start
- Mar 2026
- Primary completion
- Aug 2028
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of TRX319 in primary progressive multiple sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), sponsored by Tr1X. Started Mar 2026; status: recruiting.
02
Drugs
TRX319
03
Conditions
primary progressive multiple sclerosis (PPMS)Secondary Progressive Multiple Sclerosis (SPMS)
Beyond the preview
Go deeper on NCT07477639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07477639.